Back to Agenda
TOPIC 2 SESSION 4: The Role of the Qualified Person Responsible for Pharmacovigilance
Session Chair(s)
Gaby L. Danan, MD, PHD
Pharmacovigilance Expert, GLD, France
Phil Tregunno
Deputy Director - Patient Safety Monitoring, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Speaker(s)
Vicki Edwards, RPH
Vice President, Pharmacovigilance Excellence and International QPPV, Abbvie, United Kingdom
The Role of the Qualified Person Responsible for Pharmacovigilance
Margaret Anne Walters
Deputy EU Qualified Person for Pharmacovigilance, Merck, Sharp & Dohme Ltd, United Kingdom
The Role of the Qualified Person Responsible for Pharmacovigilance
Have an account?
